Compound Detail
CHEMBL1201863
DEXLANSOPRAZOLE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL1201863 |
| Name | DEXLANSOPRAZOLE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | MJIHNNLFOKEZEW-RUZDIDTESA-N |
| Therapeutic | ✓ Yes |
3
Targets
4
Activities
1
Assay Types
0
PK Parameters
13
Publications
11
Known Names
6
Indications
1
Mechanisms
Molecular Properties
369.4
MW (Da)
3.52
ALogP
4
HBA
1
HBD
73.9
PSA (Ų)
0.70
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2009 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Potassium-transporting ATPase inhibitor | INHIBITOR | Potassium-transporting ATPase | ✓ | ✓ |
Indications
Esophagitis Gastroesophageal Reflux Heartburn Peptic Ulcer Esophagitis, Peptic Barrett Esophagus
ATC Classification
A02BC06
dexlansoprazole
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: DRUGS FOR ACID RELATED DISORDERS
Activity Summary
IC50 4 meas. best 5.48
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NAD(+) hydrolase SARM1 CHEMBL4523350 | IC50 | 5.48 | 5.47 | 3300.0 | 2 |
| Histone-lysine N-methyltransferase 2A/WDR5 CHEMBL3883320 | IC50 | 5.24 | 5.24 | 5700.0 | 1 |
| Cytosolic endo-beta-N-acetylglucosaminidase CHEMBL5172 | IC50 | 4.6 | 4.6 | 25000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NAD(+) hydrolase SARM1 | IC50 | = | 3300.0 | nM | 5.48 | Inhibition of StrepTag-tagged human SARM1 TIR (561 to 724 residues) expressed in... | - |
| NAD(+) hydrolase SARM1 | IC50 | = | 3500.0 | nM | 5.46 | Inhibition of StrepTag-tagged human SARM1 TIR (561 to 724 residues) expressed in... | - |
| Histone-lysine N-methyltransferase 2A/WDR5 | IC50 | = | 5700.0 | nM | 5.24 | Inhibition of MLL1-WDR5 interaction in human MV4-11 cells assessed as reduction ... | 31923859 |
| Cytosolic endo-beta-N-acetylglucosaminidase | IC50 | = | 25000.0 | nM | 4.6 | Inhibition of recombinant human C-MYC/DDK-tagged ENGase expressed in HEK293T cel... | 28512024 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 26948801 | 10.1016/j.drudis.2016.02.015 | Homo sapiens | 2 |
| 23956101 | 10.1093/toxsci/kft176 | Bile salt export pump | 1 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 2 | 1 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 3 | 1 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 4 | 1 |
| 28512024 | 10.1016/j.bmcl.2017.05.010 | Cytosolic endo-beta-N-acetylglucosaminidase | 1 |
| - | 10.1101/2020.04.21.054387 | SARS-CoV-2 | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | MV4-11 | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | MOLM-13 | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | K562 | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | L02 | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | HUVEC | 1 |
| 31923859 | 10.1016/j.ejmech.2019.112027 | Histone-lysine N-methyltransferase 2A/WDR5 | 1 |
Data from ChEMBL 36 via Core Engine